发布时间:
2026
-
07
-
29
On July 9, at the 2026 Potential Unicorn Enterprise (Wuxi) Development Conference held in Wuxi, Jiangsu, Great Wall Strategy Consulting unveiled the GEI China Potential Unicorn Enterprise Research Report 2026, the seventh edition of this series. Six Efung Capital portfolio companies—TriArm Therapeutics, Shensi Biopharma, Meichuang Medical, Xunlu Biotech, Yinming Biotech, and Jiyin Biotech—were honored on the list.As a new economy consulting firm that pioneered the systematic research and release of unicorn enterprise reports in China, Great Wall Strategy Consulting has continuously resear...
浏览次数:2